Showing 911-920 of 1025 results for "".
Case Studies: Presbyopia- Correcting IOLs
https://crstoday.com/topics/general/crst0406_14-html/41064/Consultants' Roundtable
https://crstoday.com/crst-issues/2002-jun/0602_201-html/40158/As refractive surgeons continue to speculate on how current economic conditions will affect the future of our industry, exciting breakthroughs in technology and surgical techniques show great promise in resurrecting sagging surgical volume. In an effort to help practices maneuver through these uncerDifferentiated Treatments for Dry Eye Disease (DED)
https://crstoday.com/crst-supplements/differentiated-treatments-for-dry-eye-disease-ded/differentiated-treatments-for-dry-eye-disease-ded/45419/Whether DED presents as evaporative, inflammatory, or both, physicians have a variety of tools in their treatment armamentarium.The Best of 2013
https://crstoday.com/topics/general/the-best-of-2013/42386/Members of Cataract & Refractive Surgery Today's editorial advisory board chose the year's best surgical pearls, research, and technology.Past Lessons, Future Directions
https://crstoday.com/topics/practice-management/past-lessons-future-directions/43503/CRST held a roundtable discussion of private equity in ophthalmology. Participants drew on their experience with physician practice management companies to advise doctors on the consolidation efforts of today.Evaluating the Impact of Laser-Assisted Lens Capsulotomy
https://crstoday.com/topics/general/evaluating-the-impact-of-laser-assisted-lens-capsulotomy/42832/There are two sides to the story.The Economics of Innovation in Rare Eye Disease: Lessons from Epithelium-On Corneal Cross-Linking
https://crstoday.com/crst-supplements/the-economics-of-innovation-in-rare-eye-disease-lessons-from-epithelium-on-corneal-cross-linking/the-economics-of-innovation-in-rare-eye-disease-lessons-from-epithelium-on-corneal-cross-linking/54527/Presbyopia Perspectives: A Global Discussion
https://crstoday.com/crst-issues/2022-aug/presbyopia-perspectives-a-global-discussion/44806/A virtual roundtable showcasing surgeons’ preferred treatments and patient selection for pharmacologic agents, premium IOL technologies, and refractive procedures.- Thomas W. Samuelson, MDhttps://crstoday.com/profiles/thomas-w-samuelson-md/jpNZxQ/
- Thomas W. Samuelson, MDhttps://crstoday.com/profiles/thomas-w-samuelson-md/LkkGe8/